These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 922120)

  • 1. Effect of hemostasis modifiers of the activity of VP 16 213 on Lewis lung carcinoma.
    Cattan A; Pourny C; Carpentier Y; Cattan E; Barouh M
    Biomedicine; 1977 Jul; 27(5):203-8. PubMed ID: 922120
    [No Abstract]   [Full Text] [Related]  

  • 2. Antimetastasis effect of two derivatives of epiposophyllotoxin in mice.
    Cattan A; Pourny C; Carpentier Y; Cattan E; Barouh M
    Eur J Cancer (1965); 1976 Oct; 12(10):797-805. PubMed ID: 976288
    [No Abstract]   [Full Text] [Related]  

  • 3. Antitumor activity of a novel podophyllotoxin derivative (TOP-53) against lung cancer and lung metastatic cancer.
    Utsugi T; Shibata J; Sugimoto Y; Aoyagi K; Wierzba K; Kobunai T; Terada T; Oh-hara T; Tsuruo T; Yamada Y
    Cancer Res; 1996 Jun; 56(12):2809-14. PubMed ID: 8665518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity and pharmacokinetics of teniposide in Lewis lung carcinoma-bearing mice.
    Broggini M; Colombo T; D'Incalci M
    Cancer Treat Rep; 1983 Jun; 67(6):555-9. PubMed ID: 6861161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclophosphamide chemotherapy of intrapulmonarily implanted Lewis lung carcinoma.
    Ho W; Furst A
    Proc West Pharmacol Soc; 1978; 21():397-400. PubMed ID: 693524
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of (plus or minus)-1,2-bis(3,5-dioxopiperazin-1-yl)propane on tumor blood vessels and its relationship to the antimetastatic effect in the Lewis lung carcinoma.
    James SE; Salsbury AJ
    Cancer Res; 1974 Apr; 34(4):839-42. PubMed ID: 4814996
    [No Abstract]   [Full Text] [Related]  

  • 7. Biologic characterization of the subcutaneously implanted Lewis lung tumor.
    Mayo JG
    Cancer Chemother Rep 2; 1972 Nov; 3(1):325-30. PubMed ID: 4660735
    [No Abstract]   [Full Text] [Related]  

  • 8. Rotational stress reduces the effectiveness of antitumor drugs in mice.
    Giraldi T; Perissin L; Zorzet S; Rapozzi V
    Ann N Y Acad Sci; 1994 Nov; 741():234-43. PubMed ID: 7825811
    [No Abstract]   [Full Text] [Related]  

  • 9. Etoposide (VP 16-213; VePesid).
    Med Lett Drugs Ther; 1984 May; 26(661):48-9. PubMed ID: 6325855
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of anaplastic carcinoma of the lung with VP 16-213].
    Sanz Ortíz J; Saiz García F
    Med Clin (Barc); 1982 Oct 16-31; 79(7):322-4. PubMed ID: 6294420
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of oxalysine on pulmonary metastases of Lewis lung carcinoma in mice].
    Yue XF; Wu FG; Xu B
    Zhongguo Yao Li Xue Bao; 1985 Sep; 6(3):198-200. PubMed ID: 2943127
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of tranexamic acid and urokinase on hematogenous metastases of Lewis lung carcinoma in mice.
    Tanaka N; Ogawa H; Tanaka K; Kinjo M; Kohga S
    Invasion Metastasis; 1981; 1(3):149-57. PubMed ID: 7188385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antineoplastic activity of planar rhodium(I) complexes in mice bearing Lewis lung carcinoma and P388 leukemia.
    Sava G; Zorzet S; Mestroni G; Zassinovich G
    Anticancer Res; 1985; 5(3):249-52. PubMed ID: 4015038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between heparin and adriamycin in mice bearing the Lewis lung carcinoma.
    Colombo T; Delaini F; Ferrari R; Donati MB; Donelli MG; Poggi A
    Biomedicine; 1981 Dec; 34(3):124-8. PubMed ID: 7337798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Increase in the antitumor effect of doxorubicin by complex corrections of the status of the hemostasis system].
    Liubina LV; Baluda VP; Ziablitskiĭ VM; Mikhal'skaia TIu; Lepekhin VP
    Biull Eksp Biol Med; 1995 Feb; 119(2):204-6. PubMed ID: 7670055
    [No Abstract]   [Full Text] [Related]  

  • 16. [Combination of etoposide with cisplatin or cyclophosphamide in the treatment of mouse Lewis lung carcinoma].
    Uchida T; Okamoto K; Nishikawa K; Takahashi K
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):75-9. PubMed ID: 3753643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Etoposide: VP-16].
    Dicato M
    Bull Soc Sci Med Grand Duche Luxemb; 1982; 119(2):15-8. PubMed ID: 7160031
    [No Abstract]   [Full Text] [Related]  

  • 18. Response rate and toxicity of etoposide (VP-16) in squamous carcinoma of the lung: report from the Lung Cancer Treatment Study Group.
    Anderson G; Payne H
    Semin Oncol; 1985 Mar; 12(1 Suppl 2):21-2. PubMed ID: 3883504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VP-16-213 therapy in patients with small-cell carcinoma of the lung after failure on combination chemotherapy.
    Tempero M; Kessinger A; Lemon HM
    Cancer Clin Trials; 1981; 4(2):155-7. PubMed ID: 6265110
    [No Abstract]   [Full Text] [Related]  

  • 20. Flow-cytometric analysis of DNA distribution after VP16-213 treatment of Lewis lung carcinoma.
    Erba E; Ubezio P; Colombo T; Broggini M; Torti L; Vaghi M; D'Incalci M; Morasca L
    Cancer Chemother Pharmacol; 1983; 10(3):208-11. PubMed ID: 6861265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.